Sophie Kervyn
- Psychiatry and Mental health top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Cellular and Molecular Neuroscience top 10%
- Molecular Biology
- Small Animals top 10%
- Co-authors
- Jean‐Marie NicolasJonas HannestadHenrik KlitgaardAlain MatagneArmel StockisHugues ChanteuxKarine LeclercqYves Lamberty
- Topics
- Epilepsy research and treatment (9 papers)Pharmacological Effects and Toxicity Studies (8 papers)Neuroscience and Neuropharmacology Research (4 papers)
- Cited by
- Psychiatry and Mental healthCellular and Molecular NeurosciencePediatrics, Perinatology and Child Health
- Partner nations
- BelgiumUnited StatesSwitzerland
In The Last Decade
Sophie Kervyn
14 papers receiving 374 citations
Peers
Comparison fields: 5 of 76
- Psychiatry and Mental health 227
- Pediatrics, Perinatology and Child Health 195
- Cellular and Molecular Neuroscience 183
- Molecular Biology 66
- Small Animals 50
Countries citing papers authored by Sophie Kervyn
This map shows the geographic impact of Sophie Kervyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Kervyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Kervyn more than expected).
Fields of papers citing papers by Sophie Kervyn
This network shows the impact of papers produced by Sophie Kervyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Kervyn. The network helps show where Sophie Kervyn may publish in the future.
Co-authorship network of co-authors of Sophie Kervyn
This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Kervyn. A scholar is included among the top collaborators of Sophie Kervyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Kervyn. Sophie Kervyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 8 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 125 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 123 | |
| 9 | In Vitro Pharmacokinetic Profile of Brivaracetam (BRV) Reveals Low Risk of Drug-Drug Interaction (DDI) and Unrestricted Brain Permeability (P4.276) | 4 |
| 10 | 6 | |
| 11 | 46 | |
| 12 | 68 | |
| 13 | 5 | |
| 14 | 1 |
About Sophie Kervyn
Sophie Kervyn is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Small Animals, having authored 14 papers that have together received 407 indexed citations. Recurring topics across this work include Epilepsy research and treatment (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (4 papers). The work is most often cited by research in Psychiatry and Mental health (227 citations), Cellular and Molecular Neuroscience (183 citations) and Pediatrics, Perinatology and Child Health (195 citations). Sophie Kervyn has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Jean‐Marie Nicolas, Jonas Hannestad, Henrik Klitgaard, Alain Matagne, Armel Stockis, Hugues Chanteux, Karine Leclercq, Yves Lamberty, Christian Wolff and Isabelle Niespodziany. Their work appears in journals such as Neurology, Epilepsia and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.